Key result
Hyperuricemia affects ~57% of patients presenting with acute ischemic stroke.
Why the study?
There is inadequate data on the frequency of raised serum uric acid in patients with ischemic stroke in the Pakistani population.
Cross-Sectional (n=96)
No
Hyperuricemia prevalence in ischemic stroke merits prospective evaluation; leaves open causality and therapeutic implications.
Objective: To define the rate of raised serum uric acid in patients with Stroke.Study Design: Cross-sectional study.Place and Duration of study: The study was carried out in the Department of Medicine, Military Hospital, Rawalpindi, Pakistan, from 13th July 2017 to 12th January 2018.Materials and Methods: A total of 96 cases of ischemic Stroke aged 26-74 years were selected. Cases with hemorrhagic Stroke who were consuming anti-hyperuricemia medications, diuretics, and Gout were excluded. Patients who fulfilled the clinical or radiological diagnostic criteria of Stroke underwent laboratory tests which included serum uric acid levels, fasting lipid profile, 24hrs urine for creatinine clearance and proteinuria, blood sugar levels, and renal profile.Results: Among 96 patients from 26 to 74 years of age, with a mean of 54.01 ± 12.42 years. Fifty six cases (58.33%) were from 51 to 74 years of age, 48 (50.0%) were male, and 48 (50.0%) were females. Hyperuricemia was found in 55 (57.29%) patients, whereas there was no Hyperuricemia in 41 (42.71%) patients. Conclusion: The rate of raised serum uric acid is high in patients with Stroke.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2023) conducted a cross-sectional in Ischemic Stroke (n=96). Hyperuricemia (raised serum uric acid) was evaluated on Rate of raised serum uric acid (hyperuricemia). Raised serum uric acid (hyperuricemia) was highly prevalent, affecting 57.29% of patients presenting with ischemic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: